LifeStance Health Group LFST Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Operating margin | 1.7%+4.3pp | -2.6%+15.3pp | -17.9%+6.5pp | -24.5%+18.4pp | |
| Net margin | 0.7%+4.7pp | -4.1%+13.6pp | -17.6%+7.4pp | -25.1%+26.4pp | |
| Returns | |||||
| Return on equity | 0.7%+4.2pp | -3.5%+9.1pp | -12.6%+1.4pp | -14.1%+13.0pp | |
| Return on invested capital | 1.1%+2.9pp | -1.8%+8.3pp | -10.1%+2.1pp | -12.2%+7.5pp | |
| Efficiency | |||||
| Asset turnover | 0.7×+0.1× | 0.6×+0.1× | 0.5×+0.1× | 0.4×0.0× | |
| Liquidity | |||||
| Current ratio | 1.7×+0.3× | 1.4×+0.3× | 1.1×-0.2× | 1.3×-1.0× | |
| Leverage | |||||
| Debt-to-equity | 0.3×0.0× | 0.3×0.0× | 0.4×0.0× | 0.3×+0.2× | |
| Net debt / EBITDA | 2.9×-5.8× | 8.6×— | —— | —— | |
| Per Share | |||||
| Book value per share | $3.89+1.9% | $3.81-1.9% | $3.89-9.0% | $4.27-9.4% | |
| Valuation | |||||
| Market capitalization | $2.74B-2.9% | $2.82B-4.9% | $2.97B+59.7% | $1.86B-44.4% | |
| Price / earnings | 283.4×— | —— | —— | —— | |
| Price / sales | 1.9×-0.3× | 2.3×-0.6× | 2.8×+0.6× | 2.2×-2.8× | |
| Price / book | 1.8×-0.1× | 1.9×-0.1× | 2.1×+0.9× | 1.2×-0.9× | |
| EV / EBITDA | 37.6×-44.7× | 82.3×— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do LifeStance Health Group's ratios come from?
- Every ratio is computed from LifeStance Health Group's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.